Zydus Lifesciences Limited has earned USFDA approval for Niacin Extended-Release Tablets used to treat high cholesterol.

Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

New Delhi: Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the ...

Jaythari is indicated for the treatment of DMD, a rare and genetic disease that results in ongoing muscle weakness and degeneration.

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets in four strengths - 6 mg, 18 mg, 30 mg, and 36 mg.

Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

BHOPAL: Three male elephants have been on a destructive spree in around 30 villages in Anuppur, Jaithari and Rajendragram ...

Jaiprakash Associates faces corporate insolvency with 25 bidders vying for acquisition, including major Indian conglomerates ...

Birlasoft, Hindustan Copper, Manappuram Finance, National Aluminum Company shares are banned from F&O Trading on 15 April 2025.

Zydus Lifesciences has some good news — it has received final USFDA approval to sell Jaythari (Deflazacort) Tablets in America. This drug helps treat Duchenne muscular dystrophy (DMD ...